| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Murat Kuloglu, Okan Ekinci, Yakup Albayrak, Ali Caykoyl. Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature. Archives of women's mental health. vol 13. issue 5. 2011-02-03. PMID:20179976. |
many studies have also noted that aripiprazole can sometimes lead to increases in psychotic symptoms, especially in the period immediately following the switch or when aripiprazole is combined with a dopamine antagonist. |
2011-02-03 |
2023-08-12 |
Not clear |
| Laurent Karila, Aviv Weinstein, Henri-Jean Aubin, Amine Benyamina, Michel Reynaud, Steven L Batk. Pharmacological approaches to methamphetamine dependence: a focused review. British journal of clinical pharmacology. vol 69. issue 6. 2010-12-06. PMID:20565449. |
a variety of medications have failed to show efficacy in clinical trials, including a dopamine partial agonist (aripiprazole), gabaergic agents (gabapentin) and serotonergic agents (ssri, ondansetron, mirtazapine). |
2010-12-06 |
2023-08-12 |
Not clear |
| Takaaki Matsuo, Yasuhiko Izumi, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neuroscience letters. vol 481. issue 2. 2010-11-22. PMID:20600606. |
aripiprazole, a dopamine d(2) receptor partial agonist, is used to treat schizophrenia. |
2010-11-22 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neuroscience letters. vol 481. issue 2. 2010-11-22. PMID:20600606. |
aripiprazole reduced intracellular dopamine content in a concentration-dependent manner. |
2010-11-22 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neuroscience letters. vol 481. issue 2. 2010-11-22. PMID:20600606. |
these results suggest that aripiprazole protects dopaminergic neurons against glutamate cytotoxicity partly by reducing intracellular dopamine content. |
2010-11-22 |
2023-08-12 |
rat |
| Hugh Myrick, Xingbao Li, Patrick K Randall, Scott Henderson, Konstantin Voronin, Raymond F Anto. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. Journal of clinical psychopharmacology. vol 30. issue 4. 2010-11-03. PMID:20571434. |
the goal of the current study was to use an established brain imaging paradigm to explore the effect of aripiprazole (final dose 15 mg over a 14-day period), a dopamine stabilizer medication, on alcohol cue-induced brain activation and drinking in alcoholics. |
2010-11-03 |
2023-08-12 |
human |
| Takashi Futamura, Satoshi Akiyama, Haruhiko Sugino, Andy Forbes, Robert D McQuade, Tetsuro Kikuch. Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20561555. |
this study investigated the effects of aripiprazole, an antipsychotic drug that has dopamine d2 receptor partial agonist activity, on established sensitization induced by methamphetamine (map) in mice. |
2010-11-02 |
2023-08-12 |
mouse |
| Takashi Futamura, Satoshi Akiyama, Haruhiko Sugino, Andy Forbes, Robert D McQuade, Tetsuro Kikuch. Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20561555. |
in contrast, sulpiride, a dopamine d2 receptor specific antagonist, and risperidone, a serotonin 5-ht2 and dopamine d2 receptor antagonist, did not show effects similar to aripiprazole. |
2010-11-02 |
2023-08-12 |
mouse |
| Robert Swif. Medications acting on the dopaminergic system in the treatment of alcoholic patients. Current pharmaceutical design. vol 16. issue 19. 2010-10-08. PMID:20482513. |
the partial dopamine agonist, aripiprazole has shown mixed efficacy. |
2010-10-08 |
2023-08-12 |
Not clear |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in pc12 cells and rat mesencephalic cultures: implication of inhibition of vesicular transport. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
pretreatment with haloperidol, spiperone, pimozide, aripiprazole and risperidone markedly inhibited high potassium-evoked dopamine release. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
haloperidol, spiperone, pimozide, chlorpromazine, aripiprazole and olanzapine evoked dopamine release, while sulpiride and risperidone had no effect. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
in addition, haloperidol, spiperone, pimozide, aripiprazole and risperidone reduced intracellular dopamine content in a concentration-dependent manner. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
instead, haloperidol, spiperone, pimozide and aripiprazole as well as reserpine transiently increased extracellular levels of dopamine metabolites. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
in addition, haloperidol, spiperone, pimozide, aripiprazole and risperidone reduced vesicular [3h]dopamine transport. |
2010-10-04 |
2023-08-12 |
rat |
| Takaaki Matsuo, Yasuhiko Izumi, Seiko Wakita, Toshiaki Kume, Yuki Takada-Takatori, Hideyuki Sawada, Akinori Akaik. Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport. European journal of pharmacology. vol 640. issue 1-3. 2010-10-04. PMID:20460122. |
these results suggest that the inhibition of vesicular dopamine transport by haloperidol, spiperone, pimozide and aripiprazole results in a reduction in vesicular dopamine content. |
2010-10-04 |
2023-08-12 |
rat |
| Jan Frölich, Martina Starck, Tobias Banaschewski, Gerd Lehmkuh. [Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. vol 38. issue 4. 2010-09-23. PMID:20617499. |
we report a case-series of seven patients with a medical history of at least two years of tic disorder treated with the partial dopamine agonist aripiprazole to illustrate its efficacy as a treatment alternative for motor and vocal tics in children and adolescents. |
2010-09-23 |
2023-08-12 |
Not clear |
| Hidehiro Oshibuchi, Ken Inada, Jun Ishigook. [Action of amygdala dopamine and effect of antipsychotics]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. vol 30. issue 2. 2010-08-03. PMID:20491283. |
aripiprazole and haloperidol equally suppressed the marked increase in extracellular dopamine levels in fear-conditioned rats, whereas haloperidol increased and aripiprazole decreased basal dopamine levels. |
2010-08-03 |
2023-08-12 |
rat |
| Taleen Der-Ghazarian, Sergios Charntikov, Fausto A Varela, Cynthia A Crawford, Sanders A McDougal. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 5. 2010-07-29. PMID:20372943. |
effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. |
2010-07-29 |
2023-08-12 |
rat |
| Taleen Der-Ghazarian, Sergios Charntikov, Fausto A Varela, Cynthia A Crawford, Sanders A McDougal. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 5. 2010-07-29. PMID:20372943. |
the purpose of the present study was to determine whether repeated treatment with the d2 partial agonist aripiprazole or the d2 antagonist haloperidol alters dopamine (da) synthesis characteristics in the dorsal striatum of young rats. |
2010-07-29 |
2023-08-12 |
rat |